Pellets made of Microcristalline Cellulose for retard formulations and innovative drug delivery. According to monographs of Microcrystalline Cellulose (Ph. Eur., USP-NF). DMF N° 18519 since July 15, 2005.
A homogeneous distribution of the active agend and the controlled release are two fundamental advantages of this dosage form.
Multiple dosage form mean more reliable formulations thanks to the homogeneous concentration of highly active agents. CELLETS® support this pioneering development. We can supply this innovative pellet in almost any particle size starting from 100 µm micropellets.
Identification
Features & Benefits
Applications & Uses
Multi-particular dosage forms have striking advantages compared to monolithic dosage forms, such as:
Altogether, this means higher safety and better compliance for your patients, and added-value for your products.
However, historically the way to successful formulation of multiparticular dosage forms was bumpy.
But: Cellets with their unique features NOW offer streamlined formulation and processing opportunities, making formulator’s life easier, and your patient ́s lives more safe.
The specific manufacturing process of Cellets provides mechanically extremely stable cores.
Low friability and solubility facilitates the layering process and improves the yield while the extreme hardness of the core makes Cellets a perfect carrier for later tabletting.
Cellets 100 provide the same core quality in sphericity and stability as coarse fractions and therefore grant comparable content uniformity and constant release profiles.
The homogeneous distribution of APIs in multiparticular dosage forms make high demands on core material characteristics:
Altogether, this means higher safety and better compliance for your patients, and added-value for your products.
As an inert odorless and tasteless excipient MCC is extremely versatile.
Cellets are made from certified MCC and pure water allowing you to multiply the benefits of neutral pellets with the unbeatable properties of MCC.
